{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:02Z","timestamp":1786120382094,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/wnf.0b013e31823c5480","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T04:31:15Z","timestamp":1326342675000},"page":"30-36","source":"Crossref","is-referenced-by-count":5,"title":["Low-Dose Glucocorticoid Therapy Complements the Pituitary-Adrenocortical System and Reduces Anxiety and Insomnia in Myasthenia Gravis Patients"],"prefix":"10.1097","volume":"35","author":[{"given":"Suguru","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwa","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinami","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Utsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis.","volume":"330","author":"Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri1571","article-title":"Stress-induced immune dysfunction: implications for health.","volume":"5","author":"Glaser","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0404.1995.tb07002.x","article-title":"Neuropsychological test performance and affect in myasthenia gravis.","volume":"91","author":"Bartel","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1176\/ajp.147.10.1297","article-title":". Cognitive effects of corticosteroids.","volume":"147","author":"Wolkowitz","year":"1990","journal-title":"Am J Psychiatry"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"key":"R6-6-20210203","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2010.03.007","article-title":". Factors influencing the health-related quality of life in Hungarian multiple sclerosis patients.","volume":"293","author":"Fuvesi","year":"2010","journal-title":"J Neurol Sci"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/rheumatology\/36.4.463","article-title":". Use of the Short Form 36 (SF36) for health status measurement in rheumatoid arthritis.","volume":"36","author":"Talamo","year":"1997","journal-title":"Br J Rheumatol"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1253\/circj.CJ-08-0407","article-title":". Health-related quality of life in patients with coronary heart disease after residential vs ambulatory cardiac rehabilitation.","volume":"73","author":"Jegier","year":"2009","journal-title":"Circ J"},{"key":"R9-6-20210203","first-page":"CD003243","article-title":". Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.","volume":"3","author":"Wileman","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0149-7634(00)00052-X","article-title":". What have we learned about cognition in myasthenia gravis A review of methods and results.","volume":"25","author":"Paul","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0033291700021644","article-title":"A scaled version of the General Health Questionnaire.","volume":"9","author":"Goldberg","year":"1979","journal-title":"Psychol Med"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S0033291700002579","article-title":"Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population.","volume":"16","author":"Lobo","year":"1986","journal-title":"Psychol Med"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00805437","article-title":". General Health Questionnaire (GHQ12 GHQ28): psychometric properties and factor structure of the scales in a Turkish primary care sample.","volume":"32","author":"Kilic","year":"1997","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"3rd, Barohn RJ, Ernstoff RM, et al.. Myasthenia gravis: recommendations for clinical research standards. Task force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":". Reliability testing of the quantitative myasthenia gravis score.","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":". Myasthenia gravis activities of daily living profile.","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":". Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.","volume":"33","author":"Besinger","year":"1983","journal-title":"Neurology"},{"key":"R18-6-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/edrv-5-1-25","article-title":"Physiological functions of glucocorticoids in stress and their relation to pharmacological actions.","volume":"5","author":"Munck","year":"1984","journal-title":"Endocr Rev"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/endo.131.1.1319329","article-title":". Feedback and facilitation in the adrenocortical system: unmasking facilitation by partial inhibition of the glucocorticoid response to prior stress.","volume":"131","author":"Akana","year":"1992","journal-title":"Endocrinology"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s100720100066","article-title":". Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements.","volume":"22","author":"Padua","year":"2001","journal-title":"Neurol Sci"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(80)92776-2","article-title":"Myasthenia gravis: a study of social, medical, and emotional problems in 26 patients.","volume":"1","author":"Sneddon","year":"1980","journal-title":"Lancet"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"II90","DOI":"10.1007\/s00415-007-2022-5","article-title":"Psychosocial aspects in patients with myasthenia gravis.","volume":"254","author":"Kohler","year":"2007","journal-title":"J Neurol"},{"key":"R23-6-20210203","first-page":"1461","article-title":". Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitisrheumatoid arthritis: relations with indices of inflammation.","volume":"85","author":"Kanik","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2007-1013493","article-title":". Dissociation of adrenal androgen and cortisol levels in acute stress.","volume":"17","author":"Parker","year":"1985","journal-title":"Horm Metab Res"},{"key":"R25-6-20210203","first-page":"1238","article-title":". Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone.","volume":"80","author":"Vermes","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-6-20210203","first-page":"1690","article-title":"Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.","volume":"77","author":"Mastorakos","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-6-20210203","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1210\/jcem.86.6.7570","article-title":". Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness.","volume":"86","author":"Beishuizen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1001\/jama.1935.02760230013004","article-title":"Myasthenia gravis: effect of treatment with anterior pituitary extract.","volume":"102","author":"Simon","year":"1935","journal-title":"JAMA"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.1971.tb30766.x","article-title":". The use of ACTH and corticosteroids in myasthenia gravis.","volume":"183","author":"Genkins","year":"1971","journal-title":"Ann N Y Acad Sci"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201201000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:29:53Z","timestamp":1786048193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201201000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31823c5480","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}